nach oben

Journal of Genetic Counseling

Erschienen in:

01.02.2009 | Original Research

Evaluation of Group Genetic Counseling for Hereditary Breast and Ovarian Cancer

verfasst von: Yolanda Ridge, Karen Panabaker, Mary McCullum, Cheryl Portigal-Todd, Jenna Scott, Barbara McGillivray

Erschienen in: Journal of Genetic Counseling | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

As demand for genetic counseling regarding hereditary cancer continues to grow, more efficient methods of providing this service must be explored. In this pilot study, group genetic counseling was offered to two different cohorts of women seeking genetic counseling for Hereditary Breast and Ovarian Cancer. Seven group sessions, designed to cover all aspects of an individual genetic counseling appointment, were conducted. Although patients were receptive to group genetic counseling, a significant proportion chose individual counseling when given the option. Advantages of group genetic counseling include shared experience and increased efficiency. Disadvantages include increased frustration at not being eligible for genetic testing, group influence on decision-making, privacy concerns, increased need for follow-up, and difficulty booking group appointments. Overall, the level of patient satisfaction with group genetic counseling was similar to that of individual counseling. The results of this pilot study suggest that further research is needed to determine whether group genetic counseling is an acceptable alternative to individual counseling.

Alexander, N. E. (1995). The effect of an educational intervention on the perceived risk of breast cancer. Journal of General Internal Medicine, 11, 92–97. doi:10.1007/BF02599584.CrossRef

Baty, B. J., Kinney, A. Y., & Ellis, S. M. (2003). Developing culturally sensitive cancer genetics communication aids for African Americans. American Journal of Medical Genetics, 118A(2), 146–155. doi:10.1002/ajmg.a.10150.PubMedCrossRef

Berliner, J. L., & Fay, A. M. (2007). Risk assessment and genetic counseling for hereditary breast and ovarian cancer: Recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 16(3), 241–260. doi:10.1007/s10897-007-9090-7.PubMedCrossRef

Brain, K., Norman, P., Gray, J., & Mansel, R. (1999). Anxiety and adherence to breast self-examination in women with a family history of breast cancer. Psychosomatic Medicine, 61, 181–187.PubMed

Calzone, K. A., Prindiville, S. A., Jourkiv, O., Jenkins, J., DeCarvalho, M., Wallerstedt, D. B., et al. (2005). Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. Journal of Clinical Oncology, 23(15), 3455–3646. doi:10.1200/JCO.2005.04.050.PubMedCrossRef

Cohen, D., Barton, G., Gray, J., & Brain, K. (2004). Health economics and genetic service development: A familial cancer genetic example. Familial Cancer, 3, 61–67. doi:10.1023/B:FAME.0000026812.87551.bf.PubMedCrossRef

Cull, A., Miller, H., Porterfield, T., Mackay, J., Anderson, E. D., Steel, C. M., et al. (1998). The use of videotaped information in cancer genetic counselling: A randomized evaluation study. British Journal of Cancer, 77(5), 830–837.PubMed

Elwood, M. J. (1999). Public health aspects of breast cancer gene testing in Canada, Part 3: A model of potential need and demand. Chronic Diseases in Canada, 20(1), 21–25.PubMed

Esplen, M. J., Hunter, J., Leszcz, M., Warner, E., Narod, S., Metcalfe, K., et al. (2004). A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer, 101(10), 2327–2340. doi:10.1002/cncr.20661.PubMedCrossRef

Esplen, M. J., Toner, B., Hunter, J., Glendon, G., Liede, A., Narod, S., et al. (2000). A supportive-expressive group intervention for women with a family history of breast cancer: Results of a phase II study. Psycho-Oncology, 9, 243–252. doi:10.1002/1099-1611(200005/06)9:3<243::AID-PON457>3.0.CO;2-I.PubMedCrossRef

Evans, D. G., Blair, V., Greenhalgh, R., Hopwood, P., & Howell, A. (1994). The impact of genetic counseling on risk perception in women with a family history of breast cancer. British Journal of Cancer, 70, 934–938.PubMed

Gladding, S. (1994). Effective group counseling. Greensboro, NC: ERIC Counseling and Student Services Clearinghouse.

Gray, S., & Olopande, O. I. (2003). Direct-to-consumer marketing of genetic tests for cancer: Buyer beware. Journal of Clinical Oncology, 21, 3191–3193. doi:10.1200/JCO.2003.12.069.PubMedCrossRef

Green, M. J., McInerney, A. M., Biesecker, B. B., & Frost, N. (2001). An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. American Journal of Medical Genetics, 103(1), 16–23. doi:10.1002/ajmg.1500.PubMedCrossRef

Green, M. J., Peterson, S. K., Baker, M. W., Harper, G. R., Friedman, L. C., Rubinstein, W. S., et al. (2004). Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility. Journal of the American Medical Association, 292, 442–452. doi:10.1001/jama.292.4.442.PubMedCrossRef

Hoskins, K. F., Stopfer, J. E., Calzone, K. A., Merajver, S. D., Rebbeck, T. R., Garber, J. E., et al. (1995). Assessment and counseling for women with a family history of breast cancer. Journal of the American Medical Association, 273(7), 577–585. doi:10.1001/jama.273.7.577.PubMedCrossRef

Julian-Reynier, C., Eisinger, F., Chabal, F., Aurran, Y., Bignon, Y. J., Nogues, C., et al. (1998). Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics. Oncology Reports, 5, 885–888.PubMed

Kent, H. (1999). Waiting list grows for BC’s Hereditary Cancer Program. Canadian Medical Association Journal, 161(9), 1175.PubMed

Lawrence, W. F., Peshkin, B. N., Liang, W., Isaacs, C., Lerman, C., & Mandelblatt, J. S. (2001). Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiology, Biomarkers & Prevention, 10, 475–481.

Lerman, C., Biesecker, B., Benkendorf, J. L., Kerner, J., Gomez-Caminero, A., Hughes, C., et al. (1997). Controlled trial of pretest education approached to enhance informed decision-making for BRCA1 gene testing. Journal of the National Cancer Institute, 89(2), 148–157. doi:10.1093/jnci/89.2.148.PubMedCrossRef

Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., et al. (1995). Effects of individualized breast cancer counseling: A randomized trial. Journal of the National Cancer Institute, 87(4), 286–292. doi:10.1093/jnci/87.4.286.PubMedCrossRef

Lerman, C., Rimer, B., Trock, B., Balshem, A., & Engstrom, P. F. (1990). Factors associated with repeat adherence to breast cancer screening. Preventive Medicine, 19, 279–290. doi:10.1016/0091-7435(90)90028-I.PubMedCrossRef

Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychology, 10(4), 259–267. doi:10.1037/0278-6133.10.4.259.PubMedCrossRef

Matloff, E. T., Moyer, A., Shannon, K. M., Niendorf, K. B., & Col, N. F. (2006). Healthy women with a family history of breast cancer: Impact of tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Journal of Women’s Health, 15(7), 843–856. doi:10.1089/jwh.2006.15.843.PubMedCrossRef

McCaul, K. D., Schroeder, D. M., & Reid, P. A. (1996). Breast cancer worry and screening: Some prospective data. Health Psychology, 15(6), 430–433. doi:10.1037/0278-6133.15.6.430.PubMedCrossRef

Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., et al. (1994). A Strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66–75. doi:10.1126/science.7545954.PubMedCrossRef

Mikkelsen, J., Sunde, L., Johansen, C., & Johsen, S. P. (2008). Psychosocial conditions of women awaiting genetic counseling: A population-based study. Journal of Genetic Counseling, 17(3), 242–251. doi:10.1007/s10897-007-9139-7.PubMedCrossRef

Sagi, M., Kaduri, L., Zlotogora, J., & Peretz, T. (1998). The effect of genetic counseling on knowledge and perceptions regarding risks for breast cancer. Journal of Genetic Counseling, 7(5), 417–434. doi:10.1023/A:1022880831996.CrossRef

Schneider, K. A., & Marnane, D. (1997). Cancer risk counseling: How is it different? Journal of Genetic Counseling, 6(2), 97–109. doi:10.1023/A:1025699732698.CrossRef

Skinner, C. S., Schildkraut, J. M., Berry, D., Calingaert, B., Marcom, P. K., Sugarman, J., et al. (2002). Precounseling education materials for BRCA testing: Does tailoring make a difference? Genetic Testing, 6(2), 93–105. doi:10.1089/10906570260199348.PubMedCrossRef

Spiegel, D., & Classes, C. (2003). Group therapy for cancer patients: A research-based handbook of psychosocial care. New York, NY: Basic Books.

Torrance, N., Mollison, J., Worsworth, S., Gray, J., Miedzybrodzka, Z., Haites, N., et al. (2006). Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomized controlled equivalence trials. British Journal of Cancer, 95(4), 435–444. doi:10.1038/sj.bjc.6603248.PubMedCrossRef

Wang, C., Gonzalez, R., Milliron, K. J., Strecher, V. J., & Merajver, S. D. (2005). Genetic counseling for BRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics, 134A, 66–73. doi:10.1002/ajmg.a.30577.PubMedCrossRef

Warner, E., Goel, V., Ondrusek, N., Thiel, E. C., Lavina, H., Lickley, A., et al. (1999). Pilot study of an information aid for women with a family history of breast cancer. Health Expectations, 2, 118–128. doi:10.1046/j.1369-6513.1999.00038.x.PubMedCrossRef

Whitaker, D. S. (2001). Using groups to help people (2nd ed.). Philadelphia, PA: Taylor & Francis.

Wonderling, D., Hopwood, P., Cull, A., Douglas, F., Watson, M., Burn, J., et al. (2001). A descriptive study of UK cancer genetics services: An emerging clinical response to the new genetics. British Journal of Cancer, 85(2), 166–170. doi:10.1054/bjoc.2001.1893.PubMedCrossRef

Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995). Identification of the breast cancer gene BRCA2. Nature, 378, 789–791. doi:10.1038/378789a0.PubMedCrossRef

Titel: Evaluation of Group Genetic Counseling for Hereditary Breast and Ovarian Cancer
verfasst von: Yolanda Ridge
Karen Panabaker
Mary McCullum
Cheryl Portigal-Todd
Jenna Scott
Barbara McGillivray
Publikationsdatum: 01.02.2009
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 1/2009
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-008-9189-5

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Evaluation of Group Genetic Counseling for Hereditary Breast and Ovarian Cancer

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Update Gynäkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Acculturation and Familiarity With, Attitudes Towards and Beliefs about Genetic Testing for Cancer Risk Within Latinas in East Harlem, New York City

Are Patient Rights to Information and Self-Determination in Diagnostic Genetic Testing Upheld? A Comparison Of Patients’ and Providers’ Perceptions

The Impact of Social Roles on the Experience of Men in BRCA1/2 Families: Implications for Counseling

Is There a Significant Trend in Prevalence of Consanguineous Marriage in Tehran? A Review of Three Generations

Cowden Syndrome: A Critical Review of the Clinical Literature

Just Genes: The Ethics of Genetic Technologies

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Update Gynäkologie